Earlier on June 29, 2012, the FDA warned that Zofran 32mg single IV dose should be avoided due to the risk of a QT interval prolongation, which can lead to Torsades de Pointes, a potentially fatal ...

Ondansetron is a prescription drug. It comes in three forms that you take by mouth: a tablet, a disintegrating tablet, and a solution. It’s also available in an intravenous (IV) form, which is ...

The 32 mg, single intravenous (IV) dose of the anti-nausea drug ondansetron (Zofran, GlaxoSmithKline) has been pulled from the market due to potential for serious cardiac risks, the FDA announced ...

The FDA has approved an intravenous formulation of esomeprazole magnesium (Nexium IV), an expanded indication for ondansetron HCl injection (Zofran), and bromfenac ophthalmic solution 0.09% (Xibrom).

The FDA is informing healthcare professionals that preliminary results from a recently completed clinical study suggest that a 32mg single intravenous dose of ondansetron (Zofran; GlaxoSmithKline ...

The dose of Zofran for hyperemesis gravidarum requiring hospitalization is a maximum of 10 milligrams via intravenous therapy (IV) every 8 hours. More typical pregnancy nausea is managed by a much ...

Zofran is available in an oral tablet, dissolvable tablet, oral solution, and intravenous (IV) solution. Healthcare providers determine the appropriate dose based on your child's age and weight.

The FDA has issued an alert to health care professionals against the use of certain intravenous bags of metronidazole, ondansetron and ciprofloxacin because of potential contamination. The warning ...

This pilot, open-label study evaluates the antiemetic efficacy and safety of a single 20-mg intravenous (IV) dose of dexamethasone combined with a single IV dose of ondansetron (32, 24, or 8 mg) in ...

It can also be injected into your muscle or through an IV. Is Zofran Safe? Zofran is approved by the Food and Drug Administration (FDA) for use to fight off nausea related to chemotherapy.

To prevent vomiting in 1 child, 5 children had to receive ondansetron (95 percent confidence interval, 3.2 to 10.6); to prevent 1 child from having to be treated by intravenous rehydration, 6 had ...